GLYGENIX THERAPEUTICS
GlyGenix Therapeutics, Inc. develops therapeutic products for the treatment of cure metabolic disorders. The company manufactures and delivers genes to cure GSD1a. It has partnerships with National Institutes of Health, Duke University, University of Florida, and Royal Philips Electronics. GlyGenix Therapeutics, Inc. was founded in 2006 and is based in Woodbridge, Connecticut.
GLYGENIX THERAPEUTICS
Industry:
Biotechnology Manufacturing Residential Therapeutics
Founded:
2006-01-01
Address:
Woodbridge, Connecticut, United States
Country:
United States
Website Url:
http://www.glygenixtherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
2033975821
Email Addresses:
[email protected]
Total Funding:
150 K USD
Technology used in webpage:
InMotion Hosting InMotion Hosting DNS
Similar Organizations
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Connecticut Innovations
Connecticut Innovations investment in Seed Round - GlyGenix Therapeutics
Official Site Inspections
http://www.glygenixtherapeutics.com
Unable to get host informations!!!